New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
‘Stopping antidepressants or not?’ New research says collaborative primary care planning between GPs and patients is key to decisions around prescribing and cessation.
RACGP welcomes maternity funding boost GPs have applauded the $6 million announcement to expand services in Hobart amid the looming closure of a private maternity ward.
Study uncovers 300 new genetic links to depression It is hoped the findings will help identify biological drivers to develop targeted treatments and more accurately predict risk.
Cerebral palsy rates fall amid healthcare advances New research finds its birth prevalence has dropped by a third in 20 years, with GPs playing a crucial role in screening and antenatal care.
Antipsychotic use in aged care ‘not ideal’ New data shows antipsychotic prescriptions significantly outweigh diagnoses, a situation unlikely to change without greater staffing support.
Exercise most benefits those with highest OA pain: Study Research indicates physical activity may be particularly important to manage depression in people with greater osteoarthritis-related pain.
Ketamine pill halves depression severity: Study As well as being more affordable and accessible, the slow-release tablet was also found to reduce patient relapses with minimal side effects.
Cost a major factor for missed genetic testing during pregnancy With no Medicare rebate, financial barriers are preventing many pregnant people from accessing non-invasive screening for common genetic conditions.
Could psychotherapy ease depression in aged care? Researchers say it also reduces an ‘over-reliance on antidepressants’, but one GP says the plan is impractical without a funding boost.